IDO1 and neoplasm: Moreover, pharmacologic inhibition of IDO1 with 1-MT not only reduced tumor growth but also increased STING level and activation under cisplatin, RT, or diABZI treatment (Fig. 3J, K and Supplementary Fig. 3N, O).